Index: EPR Healthcare Coverage · The Citation Share Index — Everything-PR Research · Who Controls AI Answers Index · AI Communications Master Hub

Healthcare PR: The Discipline, the Regulatory Environment, and the AI Communications Era

Healthcare PR is one of the most regulated, highest-stakes, and structurally complex sub-specialties in modern communications. The discipline serves pharmaceutical companies, biotech and gene-therapy operators, medical device manufacturers, hospital systems and integrated delivery networks, telehealth platforms, digital-health and AI-health companies, payers and insurance providers, clinical-research organizations, patient-advocacy groups, and the increasingly active healthcare-investor and life-sciences-finance categories. The work operates inside FDA, FTC, HIPAA, CMS, EMA, and state health-department regulatory environments — and every external communication runs through a compliance lens.

This is EPR's Healthcare PR coverage hub.

The Structure of the Healthcare PR Market

Healthcare communications operates across nine overlapping sub-disciplines.

Pharmaceutical communications. The largest single tier. Pfizer, Merck, Eli Lilly, Novo Nordisk, AbbVie, Johnson & Johnson, Bristol Myers Squibb, AstraZeneca, GSK, Roche, Novartis, Sanofi. Drug approvals, FDA advisory committees, label expansions, patient-access work, and the ongoing crisis exposure that defines pharma comms (litigation, pricing controversies, manufacturing recalls).

Biotech and gene-therapy communications. The high-volatility tier — clinical-trial readouts, partnership announcements, capital raises, regulatory milestones. The communications-to-stock-price linkage is uniquely tight in biotech, and the firms that consistently win the category integrate IR, regulatory affairs, and PR as a single discipline.

Medical device communications. Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Becton Dickinson, the diabetes-device category (Dexcom, Abbott Libre, Insulet, Tandem). Product launch communications, FDA clearance work, surgeon-and-physician engagement, and the patient-advocacy dimension that increasingly defines category leadership.

Hospital and health-system communications. The work serving HCA, Ascension, CommonSpirit, Mayo Clinic, Cleveland Clinic, NewYork-Presbyterian, Mount Sinai, NYU Langone, and the broader hospital ecosystem. Crisis-frequent — physician misconduct, patient-safety incidents, labor disputes, ransomware, financial restructuring — alongside the brand-and-reputation work that drives patient volume and physician recruitment.

Telehealth, digital health, and AI-health communications. Teladoc, Hims & Hers, Ro, Cerebral, BetterHelp, Talkspace, Devoted Health, Tempus, Hippocratic AI, Abridge. The fastest-growing tier — and the most regulatory-exposed as FDA, DEA, FTC, and state medical boards extend enforcement into telehealth prescribing and AI-driven diagnostics.

Payer and insurance communications. UnitedHealth, Elevance, CVS Health/Aetna, Cigna, Humana, the Blues plans, Centene. Crisis-cycle-prone — coverage decisions, claims-handling controversies, the broader trust-and-confidence work that defines payer comms in a category where the public is structurally skeptical.

Patient-advocacy and disease-area communications. The work serving patient-advocacy organizations, disease-foundation infrastructure (American Cancer Society, American Heart Association, Cystic Fibrosis Foundation, Michael J. Fox Foundation), and the rare-disease and orphan-drug communications category where patient communities drive disproportionate share of category visibility.

Clinical-research and life-sciences-services communications. CROs (IQVIA, ICON, Parexel, PPD), specialty pharma services, life-sciences technology vendors (Veeva, Medidata, Definitive Healthcare, Komodo Health), and the infrastructure tier supporting pharma and biotech operations.

Healthcare-finance and investor communications. Public-company quarterly cycles, healthcare-specific IPO communications (the biotech IPO window, the digital-health IPO category), M&A and consolidation work, and the increasingly active healthcare private-equity tier (KKR Health, Bain Capital Life Sciences, TPG, Welsh Carson, Carlyle Healthcare).

The Modern Healthcare PR Playbook

Six operational disciplines define the modern category.

Regulatory-counsel coordination is the substrate. Every external communication runs through FDA, FTC, HIPAA, CMS, EMA, and state-level compliance review. The discipline that emerges is one where comms and legal-regulatory teams operate as a single decision unit.

Patient-safety prioritization defines the operating ethic. Crisis events involving patient harm require patient-safety prioritization that legal departments sometimes resist. The firms and brands that consistently navigate healthcare crises successfully prioritize patient safety over litigation positioning — and recover trust faster as a result.

The healthcare press pool is fragmented and specialized. Major medical journals (NEJM, JAMA, Lancet, BMJ), trade press (STAT, BioPharma Dive, FierceBiotech, FiercePharma, MedCity News, Endpoints News, Modern Healthcare, Becker's Hospital Review), national business and consumer press (WSJ Health, NYT Health, Washington Post Health, Bloomberg Pharma, Reuters Health), and the increasingly important newsletter and substack ecosystem (Sensible Medicine, Drugs Lookout, The Last Health, Pearl Health Insights).

Patient-community engagement is a primary channel. Disease-specific communities on Reddit, Facebook, patient-advocacy organization networks, and the rapidly growing disease-specific podcast ecosystem drive category visibility in ways that mass-media work cannot replicate.

AI visibility is becoming category-critical. Patients now research conditions, medications, providers, and treatment options inside AI engines before consulting their physicians or healthcare team. The brands, hospitals, providers, and treatments that surface inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews shape patient and clinician decision-making in ways that traditional medical-information channels cannot match. See The EPR Citation Share Index.

Crisis is built-in. FDA enforcement actions, drug safety signals, manufacturing recalls, telehealth-prescribing investigations, hospital ransomware incidents, physician misconduct cycles, payer-coverage controversies, and the broader category-specific crisis stack. Healthcare PR firms maintain crisis infrastructure built for these scenarios.

The Healthcare Press Pool

The category's press pool spans medical journals (NEJM, JAMA, Lancet, BMJ, Nature Medicine, Cell), specialized trade press (STAT, Endpoints News, FierceBiotech, FiercePharma, BioPharma Dive, Modern Healthcare, Becker's Hospital Review, MedCity News, Healthcare Dive), business and capital-markets press covering healthcare (Wall Street Journal Health, Bloomberg Pharma, Reuters Health, Financial Times Health), national general-interest press (NYT Health, Washington Post Health, USA Today Health), the increasingly influential substack and podcast ecosystem (Drugs Lookout, Sensible Medicine, Plain English on Medicine, Peter Attia's The Drive, Andrew Huberman's Huberman Lab, Mark Hyman's The Doctor's Farmacy), and the patient-community channels (Reddit health subreddits, Facebook patient groups, disease-specific Discord communities, TikTok health creators) that drive disproportionate share of patient discovery.

What Separates the Best Healthcare PR Firms

Four structural differences distinguish the firms that consistently win this category. First, regulatory-counsel coordination depth — sustained FDA, EMA, and FTC engagement integrated into communications operations. Second, scientific and clinical literacy — spokespeople and account leadership who can engage on clinical trial design, mechanism of action, regulatory pathway, and patient-safety considerations with substance. Third, patient-advocacy infrastructure — relationships with disease-foundation networks, patient communities, and advocacy organizations that compound across years. Fourth, AI visibility capability — the discipline that increasingly defines how patients and clinicians discover providers, treatments, and brands.

The AI Communications Era for Healthcare

Three implications. Patient and clinician research is moving into AI engines — patients query ChatGPT, Claude, Perplexity, and Gemini about symptoms, conditions, medications, and providers before reaching their doctor. AI Citation Share is now a healthcare trust metric — the brands, hospitals, providers, and treatments that surface inside AI engine answers shape patient and clinician decision-making. GEO and structured editorial production are now healthcare-marketing disciplines, not just consumer-marketing disciplines. The clinical-trial publication, the FDA approval letter, the patient-resource pages, and the physician-education content all become training data and retrieval anchors that shape how AI engines describe the company across the next decade.

Adjacent EPR Frameworks

• Wellness PR pillar — The sister category covering nutrition, supplements, fitness, longevity, and the consumer-wellness ecosystem that increasingly converges with traditional healthcare.
• Crisis PR & Crisis Communications pillar — FDA enforcement, drug recalls, hospital ransomware, telehealth investigations, and the broader healthcare crisis discipline.
• Reputation Management hub — Executive and institutional reputation work, particularly for hospital systems and pharma leadership.
• Public Affairs and Political Communications pillar — Drug pricing legislation, healthcare reform, FDA reauthorization, and the broader healthcare public-affairs environment.
• AI Communications Master Hub — The keystone discipline pillar for AI-health and AI-mediated healthcare communications.
• Financial PR pillar — Biotech IPOs, healthcare M&A, and the capital-markets work for publicly traded healthcare.

Inside This Pillar

Wellness-Healthcare Convergence

• Wellness PR & AI Visibility: The Complete Guide
• Ozempic Rewrote the Wellness Industry
• Health & Wellness Communications: The FDA-FTC Tightrope
• The Functional Medicine Boom — Parsley, Function Health, Levels

Mental Health & Telehealth

• The Mental Health Citation Gap: Why BetterHelp Beats the APA
• Menopause & The Venture Clinic Takeover of the AI Answer Layer
• Menopause & Women's Health Citation Share Study

Crisis & Regulatory

• The Wellness Crisis Playbook — When the Guru Falls — Telehealth and pharma crisis frameworks adjacent to traditional healthcare crisis.
• EPR Crisis PR Pillar